2 terminated, 1 completed. 2 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Not applicable | 1 | Terminated 1 |
Follow Nicorette Lozenge Product: new trials by email Literature Review of Nicorette Lozenge Product trials Research Report on Nicorette Lozenge Product
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders Nicoderm, Nicorette 4Mg Chewing Gum, Nicorette Lozenge Product - Smoking Cessation, Harm Reduction | Phase 3 | Completed | Rose Research Center, LLC | 150 | 2024-08-29 | 2026-02-06 |
| Evaluate Harm Reduction Products as a Second Line Intervention for Adult Smokers Who Do Not Quit With NRT Nicoderm, Nicorette 4Mg Chewing Gum, Nicorette Lozenge Product - Smoking Cessation, Harm Reduction | Phase 3 | Terminated | Rose Research Center, LLC | 4 | 2023-12-27 | 2025-03-30 |
| Cytisine Compared to Combination NRT in Relapsed Smokers Cytisine, Nicoderm C-Q Transdermal Product, Nicorette Lozenge Product - Smoking Cessation, Coronary Artery Disease | Not applicable | Terminated | Ottawa Heart Institute Research Corporation | 13 | 2022-03-14 | 2023-12-08 |
Smoking Cessation (3) · Harm Reduction (2) · Coronary Artery Disease (1)
Rose Research Center, LLC (2) · Ottawa Heart Institute Research Corporation (1)
United States (2) · Canada (1)
Andrew Pipe, MD (1)